Does LeMaitre Vascular (LMAT) Trade At A Premium To Cash Flow?
LeMaitre Vascular (LMAT) Shares Dropped, So What Is Driving Attention Now?
Earnings Guidance Lift Might Change The Case For Investing In LeMaitre Vascular (LMAT)
LeMaitre Vascular (LMAT) Acquires Vascular Assets To Expand Outside North America
LeMaitre Vascular, Inc. (LMAT) Q3 2026 Earnings Call Transcript
LeMaitre to Participate in Upcoming Investor Conferences
LeMaitre Vascular (LMAT) Q3 2026 Earnings Call Transcript
Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Lowers Price Target to $86
LeMaitre Vascular Inc (LMAT) (Q3 2026) Earnings Call Highlights: 12% Organic Growth, B. ...
Citizens Maintains Market Outperform on LeMaitre Vascular, Lowers Price Target to $110
LeMaitre Vascular Q3 Earnings Call Highlights
LeMaitre: Q3 Earnings Snapshot
LeMaitre’s (NASDAQ:LMAT) Q3 2026 sales beat estimates but stock drops 11.9%
LeMaitre Q3 2026 Financial Results
LeMaitre Vascular Q3 2026 Earnings Call Transcript
LeMaitre Vascular Lowers FY2026 GAAP EPS Guidance from $2.84-$2.94 to $2.77-$2.82 vs $2.87 Est; Narrows FY2026 Sales Guidance from $274.300M-$278.300M to $274.800M-$276.800M vs $276.539M Est
LeMaitre Vascular Lowers Q4 GAAP EPS Guidance from $0.75-$0.81 to $0.70-$0.75 vs $0.78 Est; Lowers Q4 Sales Guidance from $71.100M-$73.100M to $69.900M-$71.900M vs $72.325M Est
LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026
LeMaitre Vascular (NASDAQ:LMAT): A Quality Stock for Long-Term Investors
LeMaitre Vascular: The Q2 Miss Hides A Stronger Acquisition Machine
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.